A Study of Serum Levels of Ferritin, Hepatic and Renal functions in Beta-Thalassemia Major (BTM) Patients Treated With Deferasirox (DFX) Tablets, Desferioxamine (DFO) Vial, or Combination of Both (DFX + DFO) in Thalassemia Center/Karbala

A category of inherited blood illnesses known as beta-thalassemias are defined by abnormalities in the synthesis of hemoglobin beta chains, which can result in a wide range of phenotypes, from severe anemia to people who show no symptoms at all. People who have thalassemia major typically experience severe anemia during the first two years of life, necessitating frequent red blood cell (RBC) transfusions.